Evaluating the Preemptive Use of Ofirmev to Address Post-Cesarean Pain

Abstract

Uncontrolled postpartum pain has been linked to increased opioid use, increased risk for opioid dependency, depression, and the development of persistent pain (Bateman et al., 2016). The purpose of this project is to assess the use of a preemptive dose of Ofirmev (Tylenol, acetaminophen, paracetamol) 1,000 mg IV in decreasing post-cesarean pain and consequently opioid usage within the first 24-hour postoperative period. This project will evaluate documented pain scores charted in the EPIC charting system by the obstetrics nurses at Hendricks Regional Health. The 24-hour postoperative pain scores of cesarean patients who received acetaminophen before cesarean section will be compared to those who did not receive acetaminophen. Reducing post-cesarean pain scores and opioid usage within the first 24-hours may reduce the risk of opioid dependency, persistent pain, and depression